What does health & biosciences — cost of sales mean?

The direct costs attributable to the production of goods and services sold by the Health & Biosciences segment. This includes raw materials, direct labor, and manufacturing overheads required to bring products to market.

International Flavors & Fragrances (IFF) Health & Biosciences — Cost of Sales

Screener

Other segment segments

Food Ingredients

$646M+6.1%

Scent

$375M+9.0%

Taste

$375M-0.5%

Similar metrics at other companies

IEXHealth & Science Technologies — Cost of Sales

$235.7M+8.6%

SFMHealthy grocery stores — Cost of Sales

$1.43B+4.9%

RMDSleep And Breathing Health — Cost of Sales

$479.19M+2.6%

BROSLabor costs — Cost of Sales

$129.46M+27.8%

GTL

GTLSHeat Transfer Systems — Cost of Sales

$194.6M+5.4%

SOLVHealth Information Systems — Cost of Sales

$82M-9.9%

Other financials

Income statement

See full

Revenue$2.7B-3.6%

Gross profit$1.0B-1.6%

Operating income$273.0M+130%

Net income$169.0M+117%

EPS (diluted)$0.66+117%

Balance sheet

See full

Cash & equivalents$562.0M-13.5%

Total debt$6.3B-35.5%

Total equity$14.1B+7.2%

Total assets$25.1B-11.0%

Cash flow

See full

Operating cash flow$257.0M+102%

CapEx$165.0M-7.8%

Free cash flow$92.0M+277%

Valuation

See full

Market cap$22.47B+32.5%

Enterprise value$28.25B+23.4%

P/E27.4×—

P/S2.1×+0.6×

Profitability

See full

Gross margin36.3%+0.2pp

Operating margin-3.2%-1.4pp

Net margin7.6%+5.2pp

FCF margin3.7%-1.3pp

Returns & leverage

See full

Return on equity6%+4.0pp

Debt / equity0.4×-0.3×

Current ratio1.5×-0.4×

Where this comes from

Reported directly by International Flavors & Fragrances in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The source filing: International Flavors & Fragrances’s 10-Q, filed May 5, 2026.

Filed: May 5, 2026, 4:24 PM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0000051253-26-000017

Line item	Three Months Ended March 31, 2026 / Taste	Three Months Ended March 31, 2026 / Food Ingredients	Three Months Ended March 31, 2026 / Health & Biosciences	Three Months Ended March 31, 2026 / Scent	Total
Net sales	$656	$839	$595	$651	$2,741
Cost of sales	(375)	(646)	(327)	(375)
Research & development expenses	(43)	(14)	(55)	(54)
Selling & administrative expenses	(101)	(99)	(92)	(92)
Depreciation expense add-back (a)	16	34	32	18
Adjusted Operating EBITDA	$153	$114	$153	$148	$568

Item 1. Financial Statements (Unaudited)

FAQ

What is International Flavors & Fragrances's health & biosciences — cost of sales?: International Flavors & Fragrances (IFF) reported health & biosciences — cost of sales of $327M in Q1 2026.
How has International Flavors & Fragrances's health & biosciences — cost of sales changed year-over-year?: International Flavors & Fragrances's health & biosciences — cost of sales increased by 9.7% year-over-year, from $298M to $327M.
What does health & biosciences — cost of sales mean?: The direct costs attributable to the production of goods and services sold by the Health & Biosciences segment. This includes raw materials, direct labor, and manufacturing overheads required to bring products to market.